These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1352454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A chimeric EGFR/neu receptor in studies of neu function.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Cancer Treat Res; 1992; 61():213-28. PubMed ID: 1360234
    [No Abstract] [Full Text] [Related]

  • 3. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K.
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [Abstract] [Full Text] [Related]

  • 4. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
    Ben-Levy R, Peles E, Goldman-Michael R, Yarden Y.
    J Biol Chem; 1992 Aug 25; 267(24):17304-13. PubMed ID: 1355090
    [Abstract] [Full Text] [Related]

  • 5. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 25; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 6. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.
    Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y.
    J Biol Chem; 1992 Jun 15; 267(17):12266-74. PubMed ID: 1351056
    [Abstract] [Full Text] [Related]

  • 7. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
    Guy PM, Carraway KL, Cerione RA.
    J Biol Chem; 1992 Jul 15; 267(20):13851-6. PubMed ID: 1352772
    [Abstract] [Full Text] [Related]

  • 8. The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction.
    Segatto O, Lonardo F, Wexler D, Fazioli F, Pierce JH, Bottaro DP, White MF, Di Fiore PP.
    Mol Cell Biol; 1991 Jun 15; 11(6):3191-202. PubMed ID: 1674818
    [Abstract] [Full Text] [Related]

  • 9. A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2.
    Di Fiore PP, Helin K, Kraus MH, Pierce JH, Artrip J, Segatto O, Bottaro DP.
    EMBO J; 1992 Nov 15; 11(11):3927-33. PubMed ID: 1356764
    [Abstract] [Full Text] [Related]

  • 10. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
    Lee J, Dull TJ, Lax I, Schlessinger J, Ullrich A.
    EMBO J; 1989 Jan 15; 8(1):167-73. PubMed ID: 2565808
    [Abstract] [Full Text] [Related]

  • 11. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
    Connelly PA, Stern DF.
    Proc Natl Acad Sci U S A; 1990 Aug 15; 87(16):6054-7. PubMed ID: 1974718
    [Abstract] [Full Text] [Related]

  • 12. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity.
    Di Fiore PP, Segatto O, Lonardo F, Fazioli F, Pierce JH, Aaronson SA.
    Mol Cell Biol; 1990 Jun 15; 10(6):2749-56. PubMed ID: 2188097
    [Abstract] [Full Text] [Related]

  • 13. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP.
    New Biol; 1990 Nov 15; 2(11):992-1003. PubMed ID: 1983208
    [Abstract] [Full Text] [Related]

  • 14. Receptor downregulation and DNA synthesis are modulated by EGF and TPA in cells expressing an EGFR/neu chimera.
    Lehtola L, Lehväslaiho H, Sistonen L, Beguinot L, Alitalo K.
    Growth Factors; 1989 Nov 15; 1(4):323-34. PubMed ID: 2699432
    [Abstract] [Full Text] [Related]

  • 15. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H, Sistonen L, diRenzo F, Partanen J, Comoglio P, Hölttä E, Alitalo K.
    J Cell Biochem; 1990 Mar 15; 42(3):123-33. PubMed ID: 1969420
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.
    Proc Natl Acad Sci U S A; 1988 Aug 15; 85(15):5389-93. PubMed ID: 2899889
    [Abstract] [Full Text] [Related]

  • 17. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
    Sistonen L, Hölttä E, Lehväslaiho H, Lehtola L, Alitalo K.
    J Cell Biol; 1989 Nov 15; 109(5):1911-9. PubMed ID: 2572601
    [Abstract] [Full Text] [Related]

  • 18. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
    Kim HH, Vijapurkar U, Hellyer NJ, Bravo D, Koland JG.
    Biochem J; 1998 Aug 15; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
    [Abstract] [Full Text] [Related]

  • 19. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF, Heffernan PA, Weinberg RA.
    Mol Cell Biol; 1986 May 15; 6(5):1729-40. PubMed ID: 2878363
    [Abstract] [Full Text] [Related]

  • 20. Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.
    Lhoták V, Pawson T.
    Mol Cell Biol; 1993 Nov 15; 13(11):7071-9. PubMed ID: 8413296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.